INCY

#552
Incyte Corporation - Common Stock
96.7 4 USD
-0.76%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
96.74
96.76
Range Annuel
63.92
112.29
Changement quotidien
-0.76%
Changement Mensuel
-3.58%
Evolution sur 6 mois
-6.34%
Changement Annuel
+47.22%
Clôture Précédente
97.4 8
Open
96.7 6
Low
96.7 4
High
96.7 6
Volume
577
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 19.33 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.41
ratio cours/chiffre d'affaires
3.86

Incyte Corporation - Common Stock

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Nouvelles